Navigation Links
BioSpecifics Technologies Corp. Announces XIAFLEX(TM) CORD I Study Published in New England Journal of Medicine
Date:9/3/2009

sulitis). Its strategic partner Auxilium Pharmaceuticals, Inc. has announced the acceptance of the Biologic License Application (BLA) and Priority Review by the U.S. Food and Drug Administration for injectable collagenase XIAFLEX(TM) in the treatment of Dupuytren's disease. Pfizer, Inc. is responsible for marketing XIAFLEX(TM) product in Europe.


'/>"/>
SOURCE BioSpecifics Technologies Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
2. BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference
3. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
4. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
5. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
6. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
7. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
8. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
9. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
10. Senesco Technologies Initiates Preclinical Studies for Cancer Target
11. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 Moerae Matrix, ... novel therapeutics that target inflammation and fibrosis, today ... M.D., PhD, as Chief Medical Officer. ... development strategy and programs, which include a pipeline ... and fibrotic conditions.  Bill is an accomplished strategist ...
(Date:7/6/2015)... , July 6, 2015 Celtaxsys, Inc., a ... including those with rare and orphan inflammatory disease indications, ... U.S. Food and Drug Administration (FDA) to begin a ... acebilustat (CTX-4430), in adult CF patients in the US. ... Europe will be filed soon after. ...
(Date:7/6/2015)... SUNNYVALE, Calif. , July 6, 2015   ... will report financial results for its 2015 second quarter ... after the close of the market. The ... Pacific Time on Thursday, July 23, 2015, to discuss ... Cepheid,s website at http://ir.cepheid.com at least 15 ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... Calif., March 1, 2012 A consistent theme ... relationship, technological innovation and disease treatment is progression.  ... be seen in healthcare IT, which is expected ... to the healthcare industry.  Companies must maintain a ...
... 1, 2012  In a single bound, Nepean Cancer Care ... for its prostate cancer cases to a dramatically faster ... a technique that is even quicker with Elekta,s new ... treated their first patient with prostate cancer using Integrity ...
Cached Medicine Technology:Frost & Sullivan's Global Healthcare Approach Evolves to Contend with Today's Challenges 2Frost & Sullivan's Global Healthcare Approach Evolves to Contend with Today's Challenges 3Australian Clinic Puts Prostate Cancer Radiation Therapy on Fast Track With Elekta VMAT and Integrity Digital Control System 2Australian Clinic Puts Prostate Cancer Radiation Therapy on Fast Track With Elekta VMAT and Integrity Digital Control System 3
(Date:7/6/2015)... ... July 06, 2015 , ... Human induced pluripotent stem ... are generated from adult cells, such as blood or skin, can replicate indefinitely ... body. , iPSC-derived cardiomyocytes have proven valuable in helping to ...
(Date:7/6/2015)... ... 2015 , ... “ TapGlance ” was featured on NewsWatch as part of ... the market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and ... app helps users visualize what rooms will look like before they even start renovating.. ...
(Date:7/6/2015)... ... , ... June 22, 2015, Fox News in a report titled “ Female Hair Loss Needs to ... a quarter of all women in the U.S. will suffer from thinning hair or hair ... discussed. One woman, a former beauty queen, who was interviewed for the report began losing ...
(Date:7/6/2015)... ... July 06, 2015 , ... Invitation to Cover: , ... is a large gap between the unmet health priorities in the region and ... and reduce unnecessary or ineffective treatments or procedures. , This milestone conference, sponsored ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... Olive Fertility ... the UBC 2014-2015 Post Graduate Teaching Award on behalf of the department of Family ... a very exciting field to be practicing in. The technology is changing so rapidly ...
Breaking Medicine News(10 mins):Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:Olive Fertility Centre Physician Honoured for Teaching 2
... 28 Children,s Hospital of Pittsburgh of UPMC has been ... leader in its use of healthcare information technology among pediatric ... KLAS interviewed leaders at virtually every hospital in the United ... software to order and chart under an organized program sponsored ...
... brain damage, study shows , FRIDAY, Aug. 28 (HealthDay ... to detect evidence of brain damage after concussions, potentially ... injuries. , By detecting damage from concussions early with ... could begin cognitive rehabilitation treatment and prevent complications, study ...
... Aug. 28 Dr. Will Sawyer, a Family Medicine physician in ... getting adequate information on how to PREVENT local severe ... includes, crucially, "Do NOT Touch the ,T Zone," comprised of eyes, ... are the portal of entry into the respiratory and gastro-intestinal system ...
... , NASDAQ: CRME TSX: COM , ... Corp. (NASDAQ: CRME / TSX: COM) today announced that ... from the Phase 2b clinical trial of vernakalant (oral) ... being held in Barcelona, Spain from August 29 to ...
... , , Peoria AARP ... Congressman to Tackle Issue , , PEORIA, Ill., ... break from Washington, AARP is making sure he doesn,t get a break ... a giant inflatable Rx bottle as a backdrop, armed with prescription bottles ...
... , , BOULDER, Colo., Aug. 28 ... WHOLE FOODS. , , elephantjournal.com,s editor Waylon Lewis, ... on the home page of Huffington Post, garnered 500+ comments, and ... , , To read more, please visit: , ...
Cached Medicine News:Health News:Children's Hospital of Pittsburgh of UPMC Recognized for Deepest Use of Electronic Health Records for a Pediatric Hospital in Nation 2Health News:Children's Hospital of Pittsburgh of UPMC Recognized for Deepest Use of Electronic Health Records for a Pediatric Hospital in Nation 3Health News:Scans Shed New Light on Concussions 2Health News:Solution to PREVENT Novel H1N1 (Swine Flu) From Closing Down Schools! 2Health News:Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009 2Health News:Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009 3Health News:Congressman Schock Gets Health Care Reform 'Message In A Bottle' From AARP 2
... Microscope with excellent maneuverability. Konan ... weight maintaining high quality. Easy ... by simply changing the adapter. ... has resulted in a sharp ...
... The Optimal temporary implant for use with ... The pupil dilator type 5S is a ... of the pupil during phacoemulsification. It is ... use. Indication: Expansion of the pupil during ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... anatomy of the eyelid for maximum patient ... ease of insertion. Easily removal with forceps. ... offer a slightly smaller bulb for easier ... the same clear and polished silicone as ...
Medicine Products: